Evidence map›Paper›PMID 20459140›Full record

ArticleJournal of proteome research2010

Proteomic analysis of laser microdissected melanoma cells from skin organ cultures.

Brian L Hood, Jelena Grahovac, Melanie S Flint, Mai Sun, Nuno Charro, Dorothea Becker, Alan Wells, Thomas P Conrads

Abstract read
In one paragraph

Article in Journal of proteome research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. The mechanobiome: a goldmine for cancer therapeutics.American journal of physiology. Cell physiology · 2021
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Tenascin-C Signaling in melanoma.Cell adhesion & migration · 2015
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brian L HoodDepartment of Pharmacology & Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA, USA.
Jelena Grahovac
Melanie S Flint
Mai Sun
Nuno Charro
Dorothea Becker
Alan Wells
Thomas P Conrads
VA Pittsburgh Healthcare System · USUPMC Hillman Cancer Center · US

Funding

Spectral Imaging of Melanoma Cell Adhesion &MetastasisR01CA091870 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, DOROTHEA · 2003 to 2007
$1.7M
NCI NIH HHS R01 CA091870
6 · The paper itself

Abstract

Gaining insights into the molecular events that govern the progression from melanoma in situ to advanced melanoma and understanding how the local microenvironment at the melanoma site influences this progression are two clinically pivotal aspects that to date are largely unexplored. In an effort to identify key regulators of the crosstalk between melanoma cells and the melanoma-skin microenvironment, primary and metastatic human melanoma cells were seeded into skin organ cultures (SOCs) and grown for two weeks. Melanoma cells were recovered from SOCs by laser microdissection and whole-cell tryptic digests were analyzed by nanoflow liquid chromatography-tandem mass spectrometry. The differential protein abundances were calculated by spectral counting, the results of which provides evidence that cell-matrix and cell-adhesion molecules that are upregulated in the presence of these melanoma cells recapitulate proteomic data obtained from comparative analysis of human biopsies of invasive melanoma and a tissue sample of adjacent, noninvolved skin. This concordance demonstrates the value of SOCs for conducting proteomic investigations of the melanoma microenvironment.

Indexed as

ActininHumansImmunohistochemistryMelanomaMicrodissectionProteomicsSkinTandem Mass SpectrometryTenascinTissue Culture TechniquesTumor Cells, CulturedActininACTN4 protein, humanTenascin

Identifiers

PMID20459140
PMCPMC3733114
OpenAlexW2039480255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.